Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): Asystematic review and economic evaluation
D. Papaioannou*, R. Rafia, J. Rathbone, M. Stevenson, H. Buckley Woods, J. Stevens
*Corresponding author for this work
Research output: Contribution to journal › Article › Research › peer-review
Dive into the research topics of 'Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): Asystematic review and economic evaluation'. Together they form a unique fingerprint.